Afsaneh
Afsaneh Abbariki, Holte DK
Patent application number | Description | Published |
---|---|---|
20140005216 | Nalmefene for reduction of alcohol consumption in specific target populations | 01-02-2014 |
20140005217 | Nalmefene for reduction of alcohol consumption in specific target populations | 01-02-2014 |
Afsaneh Asaei, Martigny CH
Patent application number | Description | Published |
---|---|---|
20130096922 | METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR DETERMINING THE LOCATION OF A PLURALITY OF SPEECH SOURCES - The present invention discloses a method, apparatus and computer program product for determining the location of a plurality of speech sources in an area of interest, comprising performing an algorithm on a signal issued by either one of said plurality of speech sources in the area to for iteratively recover data characteristic to said signal, wherein the algorithm is an iterative model-based sparse recovery algorithm, and wherein for each of a plurality of points in said area, the iteratively recovered data is indicative of a presence of a plurality of speech sources contributing to the signal received at each of a plurality of points in the area. | 04-18-2013 |
Afsaneh Khajavi, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20100198946 | SYSTEM AND METHOD FOR QUALITY OF SERVICE (QoS) PARAMETER CHANGE - A system and method for redirecting or duplicating a media flow to one or more alternative media presentation devices and providing updated quality of service parameters to the application server providing the media flow. The user of a mobile communication device can manually initiate the media flow change or the user can configure the media flow change to automatically transfer based on the proximity of the mobile communication device to the alternative media presentation device. If desired, the media flow can be reverted to the mobile communication device. A media flow can also be divided, such as by audio and video to different alternative media presentation devices. | 08-05-2010 |
Afsaneh Lavasanifar, Edmonton CA
Patent application number | Description | Published |
---|---|---|
20100069295 | NOVEL POLY(ETHYLENE OXIDE)-BLOCK-POLY(ESTER) BLOCK COPOLYMERS - The present invention relates to micelle-forming poly(ethylene oxide)-block-poly(ester) block copolymers having reactive groups on the polyester block therein. The biodegradability of these copolymers and their biocompatibilities with a large number of bioactive agents make them suitable as carriers for various bioactive agents. The bioactive agents, such as DNA, RNA, oligonucleotide, protein, peptide, drug and the like, can be coupled to the reactive groups on the polyester block of the copolymer. | 03-18-2010 |
20100137206 | NOVEL LIGAND GUIDED BLOCK COPOLYMERS FOR TARGETED DRUG DELIVERY - This application relates to micelle-forming poly(ethylene oxide)-block-poly(ester) block copolymers having reactive groups on both the poly(ethylene oxide) block and the poly(ester) block therein. The biodegradability of these copolymers and their biocompatibilities with a large number of bioactive agents make them suitable as carriers for various bioactive agents. The bioactive agent, such as DNA, RNA, oligonucleotide, protein, peptide, drug and the like, can be coupled to the reactive groups on the polyester block of the copolymer. A variety of targeting moieties can be coupled to the reactive group on the poly(ethylene oxide) block for targeting the bioactive agent to a particular tissue. The application also relates to a composition and method of use thereof for delivering bioactive agents. | 06-03-2010 |
20130116428 | NOVEL POLY(ETHYLENE OXIDE)-BLOCK-POLY(ESTER) BLOCK COPOLYMERS - The present invention relates to micelle-forming poly(ethylene oxide)-block-poly(ester) block copolymers having reactive groups on the polyester block therein. The biodegradability of these copolymers and their biocompatibilities with a large number of bioactive agents make them suitable as carriers for various bioactive agents. The bioactive agents, such as DNA, RNA, oligonucleotide, protein, peptide, drug and the like, can be coupled to the reactive groups on the polyester block of the copolymer. | 05-09-2013 |
Afsaneh Nakhavoli, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20150175279 | TAMPING PUNCH STATION AND METHOD OF FILLING CAPSULES IN A TAMPING PUNCH STATION - A tamping punch station for filling capsules in a capsule filling machine is described. The machine includes a rotatably drivable dosing disk with bore holes and a filling device for filling the bore holes. Tamping punches and ejection punches are held on a punch support, and vertical movement of the punch support causes the tamping punches to press filling material into the bore holes and the ejection punches to eject pellets created by the tamping punches in the bore holes. First drive means rotates the dosing disk along punches and second drive means moves the punch support. The second drive means comprises at least two spindle drives acting on the punch support with respectively one spindle nut and respectively one vertical drive spindle guided in the spindle nut and at least two drive motors, which drive respectively one of the spindle drives for vertical movement of the punch support. | 06-25-2015 |
Afsaneh Rahimi-Larijani, Novato, CA US
Patent application number | Description | Published |
---|---|---|
20110196014 | METHIONINE ANALOGS AND METHODS OF USING SAME - Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and/or antiviral properties. Also provided are methods of treatment and methods of preparation, as well as kits and unit dosages. | 08-11-2011 |
20140142189 | METHIONINE ANALOGS AND METHODS OF USING SAME - Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and/or antiviral properties. Also provided are methods of treatment and methods of preparation, as well as kits and unit dosages. | 05-22-2014 |